Terlipressin Squeaks by FDA Overview for Hepatorenal Syndrome 1
The US Meals and Drug Administration’s (FDA’s) Cardiovascular and Renal Treatment Advisory Committee narrowly instructed, by an 8-7 vote, that the company grant advertising and marketing and marketing approval to terlipressin for the therapy of hepatorenal syndrome kind 1, a…